Novel BBB-Surpassing Peptide Structure for Unlocking New Treatment Avenues

Time: 1:00 pm
day: Conference Day 1


Developing peptide-based drugs for the treatment of affective disorders

• Peptides derived from natural genomic sequences with low toxicity and the ability to surpass the blood-brain-barrier

• Exploring PTIs lead compound, PT00114, which is currently in clinical trials